Current Therapies for Chronic Hepatitis C
نویسندگان
چکیده
منابع مشابه
Current therapies for chronic hepatitis C.
Hepatitis C virus affects more than 180 million people worldwide and as many as 4 million people in the United States. Given that most patients are asymptomatic until late in the disease progression, diagnostic screening and evaluation should be performed in patients who display high-risk behaviors associated with acquisition of hepatitis C. Chronic hepatitis C is associated with cirrhosis, hep...
متن کاملCurrent therapies for chronic hepatitis B.
Chronic hepatitis B is a major public health problem and there are an estimated 400 million people worldwide infected with the Hepatitis B virus (HBV). It is one of the most common causes of hepatic cirrhosis and hepatocarcinoma. The prevalence of chronic hepatitis B varies in different geographic locations. In the Western countries, hepatitis B is the third most common cause of chronic liver d...
متن کاملCurrent and Future Therapies for Hepatitis C Virus Infection
From the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD. Address reprint requests to Dr. Liang at the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bldg. 10-9B16, 10 Center Dr., Bethesda, MD 20892-1800, or at [email protected].
متن کاملCurrent and future therapies for hepatitis C virus infection.
From the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD. Address reprint requests to Dr. Liang at the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bldg. 10-9B16, 10 Center Dr., Bethesda, MD 20892-1800, or at [email protected].
متن کاملPegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C.
Until HCV NS3/4A protease inhibitors become available at the end of 2011, the combination pegylated-interferon (PEG-IFN)-alfa and ribavirin (RBV) will remain the standard treatment for chronic hepatitis C patients. In some hepatitis C virus-infected patients, PEG-IFN plus RBV treatment against HCV should continue to be used because of side effects of new drugs such as anemia. Our Japanese exper...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmacotherapy
سال: 2011
ISSN: 0277-0008
DOI: 10.1592/phco.31.1.92